Skip to main content

Research Repository

Advanced Search

All Outputs (9)

Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial (2005)
Journal Article
Alex, J., Laden, G., Cale, A. R. J., Bennett, S., Flowers, K., Madden, L., Gardiner, E., McCollum, P. T., & Griffin, S. C. (2005). Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. Journal of thoracic and cardiovascular surgery, 130(6), 1623-1630. https://doi.org/10.1016/j.jtcvs.2005.08.018

Objective: Animal studies have shown that pretreatment with hyperbaric oxygen can induce central nervous system ischemic tolerance and also modulate the inflammatory response. We evaluated this therapy in patients undergoing cardiopulmonary bypass. M... Read More about Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial.

Adrenomedullin and tumour angiogenesis (2005)
Journal Article
Nikitenko, L. L., Fox, S. B., Kehoe, S., Rees, M. C., & Bicknell, R. (2006). Adrenomedullin and tumour angiogenesis. The British Journal of Cancer, 94(1), 1-7. https://doi.org/10.1038/sj.bjc.6602832

The angiogenic activity of peptide adrenomedullin (AM) was first shown in 1998 . Since then, a number of reports have confirmed the ability of AM to induce the growth and migration of isolated vascular endothelial and smooth muscle cells in vitro and... Read More about Adrenomedullin and tumour angiogenesis.

Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk (2005)
Journal Article
Benigni, F., Zimmermann, V. S., Hugues, S., Caserta, S., Basso, V., Rivino, L., Ingulli, E., Malherbe, L., Glaichenhaus, N., & Mondino, A. (2005). Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. Journal of Immunology, 175(2), 739-748. https://doi.org/10.4049/jimmunol.175.2.739

Technical difficulties in tracking endogenous CD4 T lymphocytes have limited the characterization of tumor-specific CD4 T cell responses. Using fluorescent MHC class II/peptide multimers, we defined the fate of endogenous Leishmania receptor for acti... Read More about Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk.

Heat shock proteins in vascular disease - a review (2005)
Journal Article
Mehta, T., Greenman, J., Ettelaie, C., Venkatasubramaniam, A., Chetter, I., & McCollum, P. (2005). Heat shock proteins in vascular disease - a review. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 29(4), 395-402. https://doi.org/10.1016/j.ejvs.2005.01.005

Introduction
There is growing evidence that heat shock proteins (HSPs), a family of stress-inducible proteins may be involved in the pathogenesis of atherosclerotic vascular diseases. Here, we systematically review the evidence behind this notion.... Read More about Heat shock proteins in vascular disease - a review.

Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2 (2005)
Journal Article
Carroll, V. A., Nikitenko, L. L., Bicknell, R., & Harris, A. L. (2005). Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(4), 736-741. https://doi.org/10.1161/01.ATV.0000157980.15710.2b

Objective - The thrombolytic therapy drug, Reteplase, is a domain deletion mutant of tissue plasminogen activator (tPA), comprising the kringle 2 and protease (K2P) domains. Some kringle domains of hemostatic proteins are antiangiogenic and promote a... Read More about Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.